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HIV human immunodeficiency virus
IEC Information, Education, Communication
M&E monitoring and evaluation
MCH maternal and child health
MTCT mother-to-child transmission (of HIV)
NGO nongovernmental organization
PHC primary health care
PMTCT prevention of mother-to-child transmission (of HIV)
UN United Nations
UNAIDS Joint United Nations Programme on HIV/AIDS
UNGASS United Nations General Assembly Special Session 





Impact of mother-to-child transmission of HIV infection 
HIV among children is an increasing problem, particularly in the countries hardest hit by the AIDS
pandemic (Table 1). It is wiping out years of progress in improving child survival and is already
responsible for substantially increasing the mortality rates of children under 5 years of age (Fig. 1).
The overwhelming majority of infected children acquire the infection through mother-to-child trans-
mission (MTCT). The prevention of HIV infection in infants and young children is now a high
priority and has been the rallying point for enhanced prevention and care efforts.
Proportion of under-5 mortality attributable to HIV/AIDS
in sub-Saharan Africa, in 1999
TABLE 1. HIV/AIDS AMONG CHILDREN, 2002
FIG. 1. IMPACT OF HIV/AIDS ON CHILD SURVIVAL IN AFRICA
Children living with HIV/AIDS 3 200 000 
Children who died of HIV/AIDS 610 000
Children newly infected with HIV 800 000
Source: Walker N. Schwartländer B, Bryce J. Meeting international goals in child survival and
HIV/AIDS. Lancet, 2002 Jul 27; 360 (9329):284-9








In the absence of intervention, MTCT rates can vary from 15% to 30% without breastfeeding and
can reach 30% to 45% with prolonged breastfeeding. Transmission can take place during pregnancy,
labour or delivery and can affect infants and young children as long as breastfeeding continues.  
Rates of transmission have been estimated as follows.
During pregnancy 5–10%
During labour and delivery 10–20%
During breastfeeding 5–20%
Overall, without breastfeeding 15–30%
Overall, with breastfeeding for 6 months 25–35%
Overall, with breastfeeding for 18-24 months 30–45%
Source: de Cock K, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, Alnwick DJ, Rogers M, Shaffer N.  Prevention of mother
to child transmission in resource-poor countries: translating research into policy and practice. JAMA,2000; 283 (9):1175-1182.
The United Nations General Assembly Special Session Declaration of Commitment
At the United Nations General Assembly Special Session (UNGASS) on HIV/AIDS in June 2001
the governments of 189 countries adopted the Declaration of Commitment on HIV/AIDS, thereby
undertaking a comprehensive programme of international and national action against the pandemic.
The Declaration established specific quantified and time-bound goals, one of which was to reduce
HIV infection among infants and young children as follows: 
“By 2005, reduce the proportion of infants infected with HIV by 20%, and by 50% by 2010,
by ensuring that 80% of pregnant women accessing antenatal care have information, counselling and
other HIV prevention services available to them, increasing the availability of and providing access
for HIV-infected women and babies to effective treatment to reduce mother-to-child transmission of
HIV, as well as through effective interventions for HIV-infected women, including voluntary and
confidential counselling and testing, access to treatment, especially antiretroviral therapy (ART)
and, where appropriate, breast-milk substitutes and provision of a continuum of care.”
The rationale for this guide
UNAIDS and its partners have developed a set of core indicators that permit the monitoring of key
international and national actions, national programme outcomes, and impact entitled National
AIDS programmes: A guide to monitoring and evaluation (UNAIDS/00.17E, June 2000).  This guide
has been widely distributed and used. As a consequence of rapid developments in HIV/AIDS pre-
vention and care in the last few years, however, some important areas are not covered. One impor-
tant shortcoming is that insufficient attention is paid to the monitoring and evaluation (M&E) of
programmes for the prevention of HIV infection in infants and young children. The present guide is
an attempt to fill this gap.
What are programmes for the prevention of HIV infection in infants and young children?
5
What are programmes for the prevention of HIV
infection in infants and young children?
In order to meet the UNGASS goal it is necessary to have a comprehensive approach to the pre-
vention of HIV infection in women, infants and young children.  For the purposes of this manual we
use the WHO definitions of infants and children as persons aged 0-11 months and 12-59 months
respectively. Interventions should be in place to address the following strategic areas (see Box 1 for
UN framework for a comprehensive approach to the prevention of HIV infection in infants and
young children).
• Primary prevention of HIV infection
Avoiding infection in women can contribute significantly to the prevention of HIV
transmission to infants and young children, as well as to other prevention goals.
HIV prevention programmes should be directed at a broad range of women at risk and
their partners. A particular effort is required in order to provide young people with relevant 
services. Because primary HIV infection during pregnancy and breastfeeding poses
an increased threat of MTCT, efforts aimed at HIV prevention should also address the needs 
of pregnant and lactating women, especially in areas of high prevalence.
• Prevention of unintended pregnancies among HIV-infected women
Most HIV-infected women in the developing world are unaware of their serostatus.
While fertility decreases with disease progression, family planning (FP) services should
nevertheless be strengthened so that all women, including those infected, can receive support 
and services for the prevention of unintended pregnancies. Women known to be infected 
with HIV should receive essential care and support services, including FP and other
reproductive health services, so that they can make informed decisions about their future 
reproductive lives. 
• Prevention of HIV transmission from HIV-infected women to their infants
A package of specific interventions has been identified for the prevention of HIV
transmission from infected mothers to their children. It includes the use of antiretroviral 
drugs (ARVs), safer delivery practices, and counselling and support for infant feeding
(Box 2). Counselling and testing play a key role in enabling HIV-infected women to learn 
about their status in good time and thus to obtain the full benefits of the package.
BOX 1. A FRAMEWORK FOR ACTION TO PREVENT HIV INFECTION
IN INFANTS AND YOUNG CHILDREN
All women prevent HIV infection
HIV-infected women prevent unintended pregnancy
HIV-infected women prevent transmission to infants and young children
HIV-infected women, provide care and support
their infant and family
• Provision of care and support to HIV-infected women and their infants and families 
Programmes for the prevention of HIV in infants and young children can help to identify 
large numbers of HIV-infected women who need special attention. The strengthening
of linkages among these and other programmes concerned with care and support services
for HIV-infected women and their infants and families can ensure that the women gain access
to the services they need. Such services may involve the prevention and treatment of opportunistic
infections, the use of ART, psychosocial and nutritional support, and reproductive health 
care, including safer delivery, FP and counselling and support for infant feeding. 
Improvements in the survival and quality of life of mothers can be expected to
be accompanied by important benefits for their children. Access to care and support should 
also enhance community support for programmes aimed at preventing MTCT and increase 
the uptake of critical interventions, e.g. HIV testing. 
Debate has recently begun on the proportion of HIV infections in infants and young children that
are attributable to unsafe injections and blood transfusions. It might seem reasonable to cover these
issues in the present guide. However, it is an operating premise of this effort that the vast majority
of infections in infants and young children result from vertical transmission, either in the peripar-
tum period or subsequently through breastfeeding. More research is needed in order to establish how
much HIV transmission to infants and young children is attributable to unsafe injections and blood
transfusions. If it emerges that this is indeed a substantial problem, additional indicators addressing
such transmission and its prevention will have to be adopted. Meanwhile, indicators on blood safe-
ty and nosocomial transmission are available in Chapter 3.11 of National AIDS programmes: A
guide to monitoring and evaluation (UNAIDS/00.17E, June 2000). 
Examples of possible interventions in each of the above strategic areas are presented in Box 2.
What are programmes for the prevention of HIV infection in infants and young children?
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BOX 2. INTERVENTIONS TO PREVENT HIV INFECTION IN INFANTS
AND YOUNG CHILDREN
Intensified prevention efforts aimed at young women. Evidence from countries with
successful programmes, such as Uganda, has demonstrated that strong leadership and
open discussion of the issues, coupled with a broad approach to prevention, can be effec-
tive in limiting HIV infection among young women. This broad approach should include
the promotion of abstinence, monogamy and condom use. The experience gained in these
countries suggests that no single approach is sufficient. The most effective and humane
way to prevent HIV in infants is to help young women, by whatever means, to remain free
from infection. 
Prevention of unintended pregnancies among HIV-infected women. Often misinter-
preted to be standard FP practice, this approach is much more than that and is crucial in
preventing HIV in infants. Many women do not know if they are infected with HIV and
hence make decisions about their reproduction without complete information. The provi-
sion of testing and counselling in FP services would allow more targeted counselling on
FP and would increase the salience the of counselling on dual protection. Furthermore,
during antenatal care many women are identified as being infected with HIV. If they are
referred for counselling on postpartum family planning with information on their infec-
tion status, it is to be expected that there will be increases in the effectiveness of such
counselling and in the likelihood that subsequent pregnancies will result from conscious
decisions.  
Use of antiretroviral drugs. The recommendations on ARV drugs for prevention of
MTCT are based on evidence on drug safety and efficacy in reducing MTCT. Of the
recommended ARV drug regimens. the choice of an ARV regimen should be made locally
by taking account of feasibility, efficacy, acceptability and cost.
Safe delivery practices. Elective caesarean section can help to reduce the risk of MTCT.
However, this intervention may not be appropriate in resource-constrained settings
because of limited availability, its cost and the risk of complications. Invasive obstetric
procedures, such as the artificial rupture of the membranes, fetal scalp monitoring and
episiotomy, may increase the risk of transmission of HIV to infants. Their use in HIV-
infected women should therefore be limited to cases of absolute necessity. 
Counselling and support for infant feeding. Breastfeeding can increase the risk of HIV
transmission by 5-20%. If breastfeeding does not occur, however, children may be
exposed to an increased risk of malnutrition or infectious diseases other than HIV. The
avoidance of breastfeeding may seem logical if a mother is HIV-infected, but striking the
necessary balance of risks is more complicated. HIV-infected mothers should receive
counselling that includes information about the risks and benefits of various infant feed-
ing options and guidance on selecting the most suitable option in each set of circum-
stances. The avoidance of all breastfeeding by HIV-infected mothers is recommended if
replacement feeding is acceptable, feasible, affordable, sustainable and safe. Otherwise,
exclusive breastfeeding is recommended during the first months of life and should be dis-
continued as soon as the conditions for replacement feeding exist. Replacement feeding
should involve the use of a suitable breast-milk substitute during the first six months.
After six months both a suitable breast-milk substitute and complementary foods should
be given.
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1. Why it is important to monitor and evaluate
programmes aimed at the prevention of HIV infection
in infants and young children at the national level
Programmes for the prevention of HIV infection in infants and young children are gaining increased
commitment and support. Many countries are expanding their programmes in response to the growing
HIV/AIDS pandemic. Such programmes are expensive and represent a major commitment of funds
and energy in the countries concerned. It is clearly necessary to set standards for monitoring and
evaluating these programmes at the national level and for assuring that the investments are yielding
the greatest possible benefit. 
National M&E should involve monitoring progress in implementation, identifying problems, refin-
ing and adaptating implementation strategies, assessing the effectiveness and impact of interven-
tions, and testing strategies for optimizing the effectiveness, impact, cost-effectiveness and sustain-
ability of the programmes. 
National programme indicators should cover the goals and the four strategic areas of the compre-
hensive framework for action to prevent HIV infection in infants and young children, including
referral linkages (i.e. prevention of HIV infection in young women; prevention of unintended preg-
nancies, especially in HIV-infected women; provision of antiretroviral drugs and counselling on
infant feeding in order to prevent transmission from HIV-infected women to their neonates; and
referral to care and support for women, their infants and their families). In addition, the indicators
should measure cross-cutting themes essential for programme development and scaling up, such as
policy development and the development of health system capacity.  
2. For whom is this manual intended?
The present guide supplements National AIDS programmes: A guide to monitoring and evaluation
and, like that manual, is intended for use by programme managers at the national level.   
3. What does this manual cover?
This manual provides guidance on M&E of national programmes for the prevention of HIV infec-
tion in infants and young children. It complements existing M&E guides, including Monitoring the
Declaration of Commitment on HIV/AIDS: Guidelines on construction of core indicators  (UNAIDS,
2002), in which there are two indicators on programmes for the prevention of HIV infection in
infants and young children (see Section 3, core indicators 5 and 6, and Table 2). It is principally
aimed at national MTCT prevention programme managers and reproductive health and HIV/AIDS
programme managers.  Its purpose is to determine the level of success of programmes for the pre-
vention of HIV infection in infants and young children, to identify areas where further support is
required and to inform adaptation and scaling-up strategies. 
What are programmes for the prevention of HIV infection in infants and young children?
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The manual presents a list of core indicators and additional indicators. All countries with pro-
grammes for the prevention of HIV infection in infants and young children should aim to cover at
least the core indicators. Countries with the need and resources to cover additional indicators are
encouraged to do so. For each indicator the manual provides guidance on: 
• its definition; 
• a rationale for its use and what it measures; 
• its measurement and the available measurement tools; 
• its strengths and limitations.  
In proposing indicators the document takes account of existing indicators, experiences and stan-
dards. Wherever possible, established indicators are recommended if adequate experience has been
gained in their use. If this is not possible, new indicators and new tools for their use are proposed.
This mainly applies to additional indicators.  
As with National AIDS programmes: A guide to monitoring and evaluation, the indicators described
in the present document are for use at the national level. However, the implications of national mon-
itoring extend beyond that level. The obtainment of national indicators requires data collection at the
local level and leads to information that is also useful at the international level. However, for mon-
itoring and evaluation to be effective at the regional or local level, more detailed information is
required than is necessary at the national level. Such detail is not covered in the present guide.
Nevertheless, many of the indicators proposed here will be useful at the provincial and district levels,
even though these levels are not the intended target.
4. Data quality
A balance has to be struck between the cost and the quality of data. National programmes should
attempt to ensure that the data obtained are of sufficient quality to support appropriate management
decisions but not too costly to collect.  In each country this requires a judgement to be made on the
necessary level of precision or quality and the costs that can be afforded.  These factors may change
over time as programmes develop, expand and become more routine.
5. Terminology
The term mother-to-child transmission of HIV (MTCT) is often used to refer to the transmission of
HIV to infants. In this guide we use MTCT to refer to the biological process of vertical transmission.  
The term prevention of mother-to-child transmission (PMTCT) is often taken to be synonymous
with the provision of ARVs to HIV-infected women in order to prevent MTCT. Because this is only
one component of the prevention strategy recommended in the present guide, we use the term
prevention of HIV infection in women, infants and young children to refer to the broad range of
recommended strategies described above. 




Definitions, including numerators and denominators where appropriate, are given below for all indi-
cators, together with information on what the indicators measure, how to measure them and their
strengths and limitations.  
1. Core indicators
The following core indicators are recommended for M&E in all countries, irrespective of the type
of epidemic. Some are newly developed whereas others have been used for several years and can
also be found in other M&E guides.
Indicators
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Core indicator 1 (for all epidemic types). Existence of guidelines
for the prevention of HIV infection in infants and young children
Definition Existence of national guidelines (either approved or in draft form) for the prevention of HIV infection
in infants and youg children and the care of infants and young children in accordance with international
or commonly agreed standards.
Guidelines should be available for all four components of the comprehensive strategy for preventing
HIV infection in infants and young children. These components are as follows (specific interventions
are given in Box 2):
1) intensified prevention efforts aimed at young women (this may or may not be specifically included
in these guidelines and may be addressed elsewhere);
2) prevention of unintended pregnancies among HIV-infected women;
3) specific interventions to prevent HIV transmission from infected mothers to their children,
including ARVs, safe delivery practices, and counselling and support for infant feeding; 
4) referral or care for HIV-infected mothers and their children.
In some countries each of these issues may be addressed as part of comprehensive national HIV/AIDS 
guidelines. In others, individual guidelines may be available. Information on HIV and infant feeding may 
be incorporated into national guidelines on the feeding of infants and young children.
Rationale National guidelines are commonly based on existing international standards or on standards about 
which there is general agreement but which have not yet been formally presented as international
guidance. Without guidelines, services of unknown quality and impact could be implemented
on an ad hoc basis, making it difficult to monitor and evaluate efforts.
What is measured The indicator identifies whether guidelines exist that are in line with international or commonly
agreed standards.
What is covered The prevention of initial infection among HIV-negative women; the prevention of unintended pregnancies
by policies and among HIV-positive women; ARV prophylaxis; safe delivery practices; counselling and support for infant 
guidelines for feeding among HIV-infected pregnant and lactating women; and referral or provision of care and
the prevention of HIV support for HIV-infected women and their children.
infection in infants and
young children? Whatever components of prevention and care are ultimately adopted, countries should adapt
their guidelines to their particular circumstances.
Measurement tools A survey among key informants at the national level or in health care facilities is used to determine 
and how to measure whether there are guidelines for each intervention prong. The key informants in this situation at
the indicator the national level are the persons responsible for HIV/AIDS, maternal and child health or infant feeding 
and nutrition. At the health facility level the key informants include practitioners and clinic directors.
When enquiries are being made as to whether such guidelines exist the following additional questions 
may be asked if time and resources allow.
• How were the guidelines formulated? (Explore the process: ask by whom and on what basis
they were formulated.) 
• Are the guidelines nationally accepted (even if only draft versions are available)?
• To what extent are they implemented? (Explore the extent of implementation and the barriers
and opportunities that were or are being encountered in implementation.) 
• How often and by whom are they updated?
The indicator should be measured and the above questions answered for each intervention as outlined 
in the indicator’s definition.
This indicator should be measured every year until guidelines are found to exist.
Strengths This indicator is not concerned with the quality of guidelines or that of their implementation.
and limitations Furthermore, because it does not capture new developments in the field, the guidelines have to be 
reassessed periodically in order to guarantee that they remain consistent with changing standards.
Indicators
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Core indicator 2 (for all countries). Number and percentage of health care
workers newly trained or retrained
Definition The number and percentage of health care workers newly trained or retrained in the minimum package 
during the preceding 12 months.
Retrained health care workers are those that have undergone in-service training, i.e. they are already
in the work force and have been practising for several years. Training includes both in-service and
preservice training.
The minimum package varies between different types of health care facility. Several kinds of facility
that may provide services for the prevention of HIV infection in infants and young children are outlined 
below, together with the services that should be available. Providers working in these settings should
be trained in each of the components mentioned.
Antenatal care (ANC) / maternal and child health (MCH) clinics: counselling on risk reduction, counselling
on infant feeding, and referral or provision of the following: HIV counselling and testing, ARV prophylaxis,
FP (including counselling on dual protection), attended delivery in birth facilities where safe obstetric 
practices are observed, long-term care.
Family planning clinics: counselling on dual protection; referral to or provision of HIV counselling,
testing and long-term care; and referral to ANC/MCH services if appropriate.
Maternity hospitals: observance of safe obstetric practices, and referral to or provision of HIV counselling
and testing, ARV prophylaxis, counselling on infant feeding, MCH services, FP and long-term care.
Primary health care (PHC) facilities: referral to HIV counselling and testing, ANC/MCH and FP.
Numerator The number of health care workers newly trained or retrained in the minimum package during
the preceding 12 months.
Denominator The total number of health care workers working in facilities that have implemented the minimum
package, with women who could benefit from it, for preventing HIV infection in women and infants.
Rationale For the purpose of planning it is important to assess the resources available to address health needs.
Before the implementation or expansion of services it is vital to know not only what facilities and
equipment are available but also what training and human resources exist. Only with this information can
health systems provide services that meet the needs of and are acceptable to the populations concerned.
What is measured This indicator quantifies the human resources that are trained in preventing HIV infection in women
and children and are available to provide the required services.
Measurement tools The numerator can be calculated on the basis of a review of training records in each facility that
and how to measure has implemented services or serves women who could benefit from the minimum package for preventing
the indicator HIV in infants and young children. If, however, such records do not exist, a survey of facilities can be 
carried out. A random sample of health care providers in these facilities should be asked about training 
they may have received in the prevention of HIV infections among infants and young children. (In some 
countries a national, provincial or district training coordinator keeps records of the training given to
individual health workers. Such data can be used instead of a facility survey.) Interviewers should 
investigate the composition of the training, which varies with the type of site. The minimum package
for each type of facility is outlined in the definition of the indicator.
The denominator, i.e. the number of staff able to provide preventive services for HIV infection among 
infants and young children, is calculated on the basis of the number of health care providers working
at sites where women could potentially receive the services included in the minimum package.
These data can be obtained from ministry and health facility records.
The numerator should be collected every year. The denominator, if based on facility surveys,
is more expensive but is necessary for the calculation of the percentage and should be obtained
every two years. After the initial collection of data it may be of interest to disaggregate data for
those health care workers who have been newly trained or retrained during the preceding 12 months 
as well as to maintain a record of how many health workers have been trained since the first time
the indicator was measured.
Indicators
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Core indicator 2 (for all countries). Number and percentage of health care
workers newly trained or retrained (continuation)
Strengths This indicator tracks the number of health workers trained to provide services for the prevention of HIV 
and limitations infection in infants and young children over time. It attempts to document increasing capacity to deliver 
preventive interventions. However, no conclusions should be drawn regarding quality, because this
is affected by the practices employed rather than by the existence of trained personnel. It should not be
expected that all health workers in all countries will have been trained, nor even that a high percentage 
of those who could be trained will have been trained. The indicator should be interpreted in relation
to the size and nature of the epidemic in particular countries.
Difficulties may occur in determining the denominator, as some countries may have limited information 
on the pool of human resources available in various facilities. Frequent transfers of personnel between 
facilities, or high rates of attrition, may complicate the interpretation of the indicator. It should be noted 
that the assumption is made that only formal health workers are counted, i.e. those remunerated either 
financially or in kind. In many settings, however, informal health workers make a significant contribution.
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Indicators
Core indicator 3 (for all epidemic types). Prevention and care service points
Definition The percentage of public, missionary and workplace venues (FP and PHC clinics, ANC/MCH, and
maternity hospitals) offering the minimum package of services for the prevention of HIV infection
in infants and young children in the preceding 12 months.
Numerator The number of public, missionary and workplace venues (FP and PHC clinics, ANC/MCH, and maternity 
hospitals) offering the minimum package of services for the prevention of HIV infection in infants
and young children in the preceding 12 months.
Denominator All public, missionary and workplace venues (FP and PHC clinics, ANC/MCH, and maternity hospitals).
Rationale In order to be effective the prevention of HIV in infants must be applied as broadly as possible
at all relevant treatment sites. It is generally acknowledged that a large proportion of preventive services
occurs in ANC settings. As services become integrated, however, it will become important to consider 
other outlets as well.
What is measured The indicator measures the coverage of the services at each of the outlets where prevention or care 
opportunities arise. These opportunities comprise either referrals to other services or the provision
of on-site services.
Measurement tools The information required for this indicator can be obtained by various methods and depends
and how to measure on resource availability and the amount of detail sought. It focuses on the minimum package
the indicator of services, which is defined, as with the previous indicator, by the type of clinical setting. An outline 
is given below of facilities that may provide services for the prevention of HIV infection in infants and 
young children, together with indications of the services that should be available.
ANC/MCH clinics: counselling on risk reduction, counselling on infant feeding, and referral or provision 
of HIV counselling and testing, ARV prophylaxis, FP (including counselling on dual protection), attended 
delivery in birth facilities where safe obstetric practices are observed, and long-term care.
FP clinics: counselling on dual protection; referral or provision of HIV counselling and testing,
and long-term care; and referral to ANC/MCH services if appropriate.
Maternity hospitals: observance of safe obstetric practices, and referral or provision of HIV counselling 
and testing, ARV prophylaxis, counselling on infant feeding, MCH services, family planning and
long-term care.
PHC facilities: referral to HIV counselling and testing, ANC/MCH and family planning.
Two options for measuring this indicator are proposed below.
Option 1
A questionnaire should be sent to all public, missionary and workplace health facilities offering FP
and PHC clinics, ANC/MCH and maternity services. It should be facility-specific, outlining the specific 
services on offer. A column should be included to show whether services are provided on site or
if referrals are made.
Scoring should not be of the “all or nothing” kind. The numerator should reflect those elements of
the package that are present (or for which there are in-house referral mechanisms). The denominator 
is all public, missionary and workplace venues (FP and PHC clinics, ANC/MCH, and maternity hospitals).
If the number of possible sites to be surveyed is too great for all to be covered a stratified random
sample can be drawn, each stratum being a different type of service delivery, and the questionnaire
can be sent to the selected sites.
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Core indicator 3 (for all epidemic types). Prevention and care service points
Measurement tools Option 2
and how to measure Other instruments can be adapted and used as exemplified below.
the indicator
For overall coverage the following instruments can be adapted.
• WHO draft protocol for the evaluation of HIV/AIDS care and support
• UNAIDS protocol for evaluation of care and support
These instruments involve the performance of surveys of health facilities.
For HIV testing and counselling the following tools can be adapted.
• UNAIDS tool for evaluating HIV voluntary counselling and testing
Irrespective of the method adopted for measuring the indicator it is essential to note the type of service 
providing the information (e.g. ANC, FP centre). This makes it possible to determine the more common 
outlets for prevention and care among women and infants.
The indicator should be measured every two to three years.
Strengths The indicator provides critical information on the national availability of prevention and care efforts 
and limitations for women and infants. While it is useful to programme planners seeking to determine where services 
are needed or where facilities are providing the full spectrum of services for preventing HIV infection
in women and infants, it cannot measure the quality of the services being provided in each facility.
Moreover, not all countries should be expected to have all, or a high percentage of all possible, health 
care service points offering services to prevent HIV in infants and young children. Rather, this indicator 




Women completing the testing and counselling process
Definition The percentage of pregnant women making at least one ANC visit who have received an HIV test
result and post-test counselling.1
Numerator The number of pregnant women who have received an HIV test result and post-test counselling
in the preceding 12 months.
Denominator The estimated number of pregnant women giving birth in the preceding 12 months who have made
at least one ANC visit.
Rationale For PMTCT to be effective, it is necessary to know a woman’s sero-status in order to tailor prevention 
and care to her needs. A successful PMTCT program will reach as many pregnant women as possible 
to ensure knowledge of sero-status.
What is measured The indicator provides a broad measure of programme coverage in the country concerned.
However, issues of poor access to services and poor uptake result in only a small percentage of women
knowing their status. It is therefore important to refer to the programme-level indicator described
in the footnote below.
Measurement tools The indicator requires that programme records be reviewed in order to count how many women have 
and how to measure completed the testing and counselling process, i.e. have received their test results and post-test
the indicator counselling. The number of women who have made at least one ANC visit is estimated by multiplying 
the number of births in the preceding 12 months, as given in a census or the best available source,
by the rate of ANC attendance (Demographic and Health Surveys-type sample survey).
In some cases the numerator may be obtainable by examining national records. If this is not possible 
the required data are likely to be available at the district level, where they can be collected directly
from facilities providing the services in question.
In some cases the denominator may be obtainable by examining national ANC registries. This is
the preferable denominator and should be used if possible. If this number is not available or reliable
the estimate of the number of pregnant women described above can be substituted but this approach 
involves an increased possibility of misinterpretation.
The indicator should be measured annually.
Strengths As stated in National AIDS programmes: A guide to monitoring and evaluation, this indicator provides
and limitations a broad measure of service provision and gives an idea of coverage in ANC settings where PMTCT 
interventions are available. It does not attempt to inform service providers about the points in
the counselling and testing cycle at which women drop out.
It is important that programme managers employ a series of lower-level indicators for determining
losses to follow-up. Because the quality of services is not being measured, information on drop-outs 
and the points at which they occur is of limited use if not followed up with operations research aimed
at discovering why women are failing to complete the cycle.
1 An additional important programme-level counselling and testing indicator must be considered when a PMTCT programme is being 
managed. The indicator measures the points in the provision of counselling and testing for pregnant women at which women drop out.
This information can be used to investigate further why women drop out at specific points, and, ultimately, to reduce the percentage
of drop-outs. Such information is therefore important for programme planning. The indicator includes the following three
components.
a) The number of pregnant women who have made at least one ANC visit and have been counselled at a PMTCT site,
divided by the total number of pregnant women.
b) The number of pregnant women who have accepted testing for HIV, divided by the total number of pregnant women
who have made at least one ANC visit and have been counselled at a PMTCT site.
c) The number of women receiving post-test counselling and HIV results, divided by the total number of pregnant women
who have made at least one ANC visit and have been counselled at a PMTCT site.
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Core indicator 5. Antiretroviral prophylaxis1
Definition The percentage of HIV-positive pregnant women receiving a complete course of ARV prophylaxis
to reduce MTCT in accordance with a nationally approved treatment protocol (or WHO/UNAIDS
standards) in the preceding 12 months.
Numerator The number of HIV-positive pregnant women receiving a complete course of ARV prophylaxis to reduce 
MTCT in accordance with a nationally approved treatment protocol (or WHO/UNAIDS standards)
in the preceding 12 months.
Denominator The estimated number of HIV-infected pregnant women giving birth in the preceding 12 months.
Rationale This is an UNGASS national programme and behaviour indicator. It is important for measuring
the outcome of providing ARV prophylaxis to pregnant HIV-positive women.
What is measured The indicator assesses progress in the prevention of MTCT by ARV prophylaxis.
Measurement tools The information is obtained by means of programme monitoring and estimates.
and how to measure 
the indicator Whether women who receive ARV prophylaxis from the private sector and NGO clinics should
be included in the calculation of the indicator is left to the discretion of the country concerned.
This decision should be based on a frank appraisal of how often ARV for pregnant HIV- infected women 
is provided outside the government sector, and should be noted and applied consistently in calculating 
both the numerator and the denominator. Private sector and NGO clinics that provide prescriptions
for ARVs but assume that the drugs will be acquired elsewhere by the individuals in question are not 
included in this indicator, even though such clinics may be the major providers of services for
the reduction of MTCT. The key feature is the actual provision of the drugs.
The number of HIV-infected pregnant women who have been provided with ARV prophylaxis during
the preceding 12 months in order to reduce the risk of MTCT is obtained from programme monitoring 
records. Only those women who have completed the full course should be included.
The number of HIV-infected pregnant women to whom ARV prophylaxis for reducing the risk of MTCT 
could potentially have been given is estimated by multiplying the total number of women who gave birth
in the preceding 12 months (central statistics office estimates of births) by the most recent national 
estimate of HIV prevalence in pregnant women (HIV sentinel surveillance antenatal clinic estimates).
A tool for the measurement of this indicator is provided in Monitoring the Declaration of Commitment on
HIV/AIDS: Guidelines on construction of core indicators (UNAIDS, 2002).
This indicator should be measured every two to three years.
Strengths This indicator has the following weaknesses.
and limitations
(1) ANC data are often incomplete and may not reflect the true situation.
(2) There may be selection bias because only those women are included who self-select
to access services.
(3) Every country has its own definition of a full course of ARV treatment.
(4) The indicator does not assess treatment compliance, and, as currently defined, measures need.
It does not assess what percentage of women accessing ANC services where PMTCT services
are available actually avail themselves of the intervention.
(5) As the number of women provided with HAART increases over time the need for specific ARV
distribution to prevent vertical transmission may lessen. It will be necessary to develop specific 
indicators in order to capture information on this matter.
1 From: Monitoring the Declaration of Commitment on HIV/AIDS: Guidelines on construction of core indicators (UNAIDS, 2002).
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Core indicator 6. HIV-infected infants born to HIV-infected mothers1
Definition The percentage of HIV-positive infants born to HIV-infected women.
Rationale This UNGASS indicator measures the impact of providing ARV prophylaxis to pregnant women
in order to prevent vertical transmission.
What is measured The indicator measures the impact on MTCT reduction of the provision of ARVs to infected women.
Measurement tools This indicator is measured by taking the weighted average of the probabilities of MTCT for pregnant 
and how to measure women receiving and not receiving ART, the weights being the proportion of women receiving and
the indicator not receiving ARVs respectively.
The indicator is calculated using the following formula.
Indicator score: {T*(1 - e) + (1 - T)}*v
Where:
T = proportion of HIV-infected pregnant women given ART ( this is the proportion obtained
in the UNGASS indicator on ARV prophylaxis, i.e. core indicator 5 of the present guide);
v = MTCT rate in absence of treatment; 
e = efficacy of treatment provided.
Default values of 0.25 and 0.50 respectively can be used for v and e. However, if scientific estimates
of the efficacy of the specific forms of treatment (i.e. combination therapies) employed in the country 
are available they should be used, and this should be noted in the calculations.
The complete tool for measuring this indicator can be found in Monitoring the Declaration
of Commitment on HIV/AIDS: Guidelines on construction of core indicators (UNAIDS, 2002).
The indicator should be calculated every two to three years.
This indicator should be measured every two to three years.
Strengths If an infant becomes positive the indicator cannot distinguish between different causes of infection,
and limitations i.e. treatment failure or infection during breastfeeding. The indicator may therefore underestimate
the rates of MTCT in countries where long periods of breastfeeding are common.
Conversely, rates may be overestimated in countries where other MTCT prevention interventions
are common, e.g. caesarean section.
T, the proportion of HIV-infected pregnant women given treatment, may be a poor estimate in places 
where the usage of ANC clinic services is low.
Indicators
1 From: Monitoring the Declaration of Commitment on HIV/AIDS: Guidelines on construction of core indicators (UNAIDS, 2002).
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Table 2 summarizes the relationship between the indicators presented and the essential elements in
the prevention of HIV in infants. 
TABLE 2. MATRIX DEMONSTRATING LINKS BETWEEN CORE INDICATORS
AND THE STRATEGIC FRAMEWORK FOR PREVENTING HIV INFECTION IN
WOMEN AND INFANTS
INPUT ➔ PROCESS ➔ OUTPUT ➔ OUTCOME ➔ IMPACT
(resources, (provider (services, (care and (incidence,
supplies, practices, IEC, treatment survival, etc.)
staff, etc.) numbers knowledge, practices,
accessed, etc.) discrimination,
etc.) etc.)
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2. Additional indicators 
Additional indicators should only be used by countries experiencing specific epidemic types and
only if there are adequate resources. The additional indicators outlined below can be used by countries
in accordance with their needs and resources. Each indicator is presented with a recommendation
concerning the most appropriate epidemic level at which it should be employed. Countries should
use their own discretion in selecting the indicators best suited to their needs.
Additional indicator 1 (for concentrated and generalized epidemics)
Women referred to FP services from ANC services offering the minimum
package to prevent HIV in infants and young children
Definition The number of HIV-infected women referred to FP services for postpartum contraception from ANC
services offering the minimum package to prevent HIV in infants and young children.
Numerator The number of HIV-infected women, calculated on the basis of estimates of prevalence of HIV
at each site, referred to FP services for postpartum contraception from ANC services offering
the minimum package to prevent HIV in infants and young children.
Denominator All women referred to FP for postpartum contraception from ANC services offering the minimum
package to prevent HIV in infants and young children.
Rationale The referral of HIV-infected women to postpartum contraception services reduces the probability
of unintended pregnancy in the future and thus reduces the overall risk of MTCT. The referral 
of HIV-negative women to such services reduces the probability of them becoming infected in the future
assuming that dual protection is advised and adopted), while helping to reduce the incidence
of unintended pregnancies.
What is measured The indicator measures the quantity of referral for postpartum contraceptive advice for HIV-positive
and non-infected women. It is directly relevant to the second prong of the strategy for the prevention
of HIV in infants and young children.
Measurement tools The indicator can be obtained by means of programme reports, monitoring tools and observation.
and how to measure Programme reports can provide an estimate of HIV prevalence at each site. Monitoring tools can
the indicator determine the number of women referred. Observation can be used to determine the extent to which 
women receive information on the most effective forms of contraception. The monitoring of FP clinic 
records can determine methods selected by referred women.
Strengths The indicator suggests the extent to which women are referred to postpartum counselling on FP
and limitations but does not attempt to ascertain either the different contraception options that are selected or
the regularity with which they are used. Consequently, it cannot reveal anything about the effectiveness 
of the advice given.
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Additional indicator 2 (for concentrated and generalized epidemics)
PMTCT services that refer to care and support facilities
Definition The percentage of venues offering the minimum package for preventing HIV in infants and young
children (see core indicator 3 for definition) which have specific written guidance on how to make
referrals to facilities offering long-term care and support.
Numerator The number of venues offering the minimum package of services which have specific written
guidance on making referrals for HIV-positive women to facilities offering long-term care
and support for HIV-infected women.
Denominator The total number of venues offering the minimum package of PMTCT services
(numerator for core indicator 3).
Rationale The indicator attempts to capture the full referral cycle.
What is measured The indicator estimates the coverage of referral services from clinics offering PMTCT services
to long-term care and support facilities for HIV-positive women.
Measurement tools The indicator can be measured during a health facility survey by asking if there is written guidance
and how to measure for referrals. If the answer is in the affirmative a copy of the guidelines should be requested
the indicator or later review.
Strengths The indicator only considers whether there is written guidance and therefore does not reveal
and limitations whether referrals are actually made.
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Additional indicator 3 (for concentrated and generalized epidemics)
Women receiving counselling on infant feeding at first infant follow-up visit
Definition The percentage of HIV-infected women receiving counselling on infant feeding at their first infant
follow-up visit.
Numerator The number of HIV-infected women receiving counselling on infant feeding at their first infant
follow-up visit.
Denominator All HIV-infected women making their first infant follow-up visit.
Rationale It is necessary to provide HIV-infected mothers with counselling on the feeding needs of their infants,
the alternatives that are available and the different risks involved with each approach, in order
that informed decisions can be made as to which approach is best in individual circumstances.
What is measured The indicator measures coverage of counselling efforts in infant feeding.
Measurement tools Reviews of clinic records can be used to determine how many HIV-infected women have made
and how to measure their first infant follow-up visit during a specified period and how many of the records indicate
the indicator that these women have been counselled on infant feeding.
Strengths One of the limitations concerns data collection methods. There is a reliance on record-keeping
and limitations by facilities. It is assumed that all encounters in which there is counselling on infant feeding are
covered by visit records and that women’s serostatuses are known. This indicator may seem
to measure an intervention that takes place rather late in the process but it is considered preferable
to asking about infant feeding intentions at the time of delivery.
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Additional indicator 4 (for all epidemic types)
Condom distribution in ANC clinics
Definition The number of condoms distributed and the average number of days out of stock in ANC clinics.
Rationale ANC clinics are a significant component of programmes for the prevention of HIV in mothers
and infants. It is therefore important to monitor the distribution of condoms and their availability
in these settings. This relates to what is sometimes an increased risk of HIV infection during pregnancy,
when men are reported to be more likely to engage in sexual behaviour with other partners.
The use of condoms during pregnancy and lactation is therefore an essential element in the prevention 
of HIV in mothers and their infants.
What is measured The indicator assesses the volume of distribution and any stockouts of condoms in ANC clinics.
Measurement tools Information on the number of condoms distributed can be obtained from programme monitoring 
and how to measure records, which usually include details of condom distribution per week, month or quarter.
the indicator If this information is not available the number of condoms ordered per quarter or some other substitute 
can be used.
In order to measure stock outs a random sample of ANC clinics is asked about the number of days 
during the preceding month on which no condoms were available for clients. The records are checked 
and the days are counted. The average number of days on which condoms were unavailable
is then presented as the indicator.
Strengths The indicator gives a measure of how many condoms are distributed and the continuity
and limitations of their availability but cannot provide information on their ultimate use.
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3. Other indicators of potential value 
HIV prevention in infants and young children cuts across a number of other programmes that may or
may not be well integrated. The information yielded by the core and additional indicators described
above can be enhanced if they are interpreted in the light of important indicators that may already be
routinely collected for the monitoring and evaluation of these other programmes. Some of these stan-
dard indicators, drawn from other guides and sources, are outlined below. If the data for these indi-
cators are readily available in countries, programme managers may find them of value in connection
with the monitoring and evaluation of efforts to prevent HIV in infants and young children.
HIV prevalence in pregnant women aged 15-24 years
• Percentage of blood samples taken from women aged 15-24 years who test positive
for HIV during routine sentinel surveillance at selected antenatal clinics.
Percentage of population aware of methods of preventing MTCT
• Percentage of women and men who correctly respond to prompted questions about
preventing MTCT through ARVs and safer infant feeding practices.
Percentage of pregnant women counselled and tested for HIV
• Percentage of women who have received counselling during ANC for their most recent
pregnancy, who accepted an offer of testing, and who received their test results, based on all 
women pregnant at any time in the two years preceding the survey in question.
Antenatal clinics offering  testing and counseling  or referral for testing
and counseling 
• Percentage of public antenatal clinics offering testing and counseling for HIV by trained
staff or referral to testing and counseling services.
Existence of comprehensive HIV/AIDS care and support policies,
strategies and guidelines
• Existence of national guidelines for long-term care and support for HIV-positive adults
and children.
Quality HIV counselling
• Percentage of post-test counselling sessions for women attending for ANC
in which counselling and voluntary HIV testing meet international standards for testing
of satisfactory quality, including referral for care where necessary.
Family planning during post-test counselling
• Percentage of HIV-positive women receiving FP information during post-test counselling.
Antenatal care coverage 
• Percentage of women who are attended at least once during pregnancy by skilled health
personnel for reasons related to pregnancy.
Percentage of births attended by skilled health personnel 
• Percentage of births attended by doctors and/or persons with midwifery skills
who can manage normal deliveries and diagnose or refer obstetric complications.
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Percentage of pregnant women attending antenatal clinics who are screened
for syphilis
Availability of basic essential obstetric care 
• Number of facilities with functioning basic essential obstetric care per 500 000 population.
Family planning method mix
• Percentage distribution of contraceptive users or, alternatively, acceptors,
for each contraceptive method.
Characteristics of users of family planning methods
• Sociodemographic profile of current users of contraceptive methods relevant
to progamme planning and/or marketing. 
Partner testing
• Percentage of male partners of women attending preventive services that is tested
and receives results.
Reported feeding choices at delivery
• Percentage of women in PMTCT programmes who report plans at delivery
to either exclusively breastfeed or exclusively use replacement feeding.
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